<DOC>
	<DOC>NCT00814151</DOC>
	<brief_summary>In-vitro identification of S. aureus, methicillin-sensitive S. aureus (MSSA), and methicillin-resistant S. aureus (MRSA) from positive blood cultures by MicroPhage's bacteriophage-based diagnostic platform.</brief_summary>
	<brief_title>MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial</brief_title>
	<detailed_description>This is a multi-center, preclinical study to investigate the effectiveness of the performance of MicroPhage S. aureus / MSSA/MRSA test direct for blood culture. There will be no patient consent, as this is a laboratory performance study on leftover specimens. The MicroPhage test will be compared to site standards (gold standard) and market-available tests with similar indications (comparators). MicroPhage will require data to be collected at 4 hours and 5 hours following the start of the MicroPhage test. The study will last 2-3 months, depending on the accrual rate of the institution.</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<criteria>Over 18 years of age. Blood culture positive, of ANY of the following bottle types: BD Bactec Standard Aerobic and Anaerobic, BD Bactec Plus Aerobic and Anaerobic, bioMerieux BacT/Alert Standard Aerobic and Anaerobic, bioMerieux BacT/Alert FAN Aerobic and Anaerobic. BD Bactec Lytic, Pediatric, or other bottle types not listed above. bioMerieux Pediatric FAN or other bottle types listed above. Trek bottles. Specimens from patients under 18 years of age.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Blood culture</keyword>
	<keyword>Staphylococcus aureus</keyword>
	<keyword>Bacteremia</keyword>
	<keyword>MRSA</keyword>
	<keyword>MSSA</keyword>
	<keyword>MicroPhage</keyword>
</DOC>